These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19640854)

  • 21. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis.
    Wu D; Guo YY; Xu NN; Zhao S; Hou LX; Jiao T; Zhang N
    BMC Musculoskelet Disord; 2015 Feb; 16(1):19. PubMed ID: 25888248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
    Braun J; Baraliakos X; Listing J; Davis J; van der Heijde D; Haibel H; Rudwaleit M; Sieper J
    Arthritis Rheum; 2007 May; 57(4):639-47. PubMed ID: 17471540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.
    Strangfeld A; Listing J
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1181-95. PubMed ID: 17127203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
    Wroński J; Fiedor P
    J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
    Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
    Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis.
    Moura CS; Rahme E; Maksymowych WP; Abrahamowicz M; Bessette L; Bernatsky S
    Scand J Rheumatol; 2019 Mar; 48(2):121-127. PubMed ID: 30112959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Golimumab, the newest TNF-α blocker, comes of age.
    Papagoras C; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2015; 33(4):570-7. PubMed ID: 25602858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
    Ravindran V; Scott DL; Choy EH
    Ann Rheum Dis; 2008 Jun; 67(6):855-9. PubMed ID: 17827183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
    Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
    Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis.
    Che H; Lukas C; Morel J; Combe B
    Joint Bone Spine; 2014 May; 81(3):215-21. PubMed ID: 23932722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
    van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
    Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of TNF-α blockers on the oral prevalence of opportunistic microorganisms in ankylosing spondylitis patients.
    Pereira DF; Pinheiro MM; Silva PF; Teodoro GR; Brighenti FL; Koga-Ito CY
    Clin Exp Rheumatol; 2012; 30(5):679-85. PubMed ID: 22935381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of antitumor necrosis factor(α) agents on patients with ankylosing spondylitis.
    Ren L; Li J; Luo R; Tang R; Zhu S; Wan L
    Am J Med Sci; 2013 Dec; 346(6):455-61. PubMed ID: 23715113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
    Haibel H; Sieper J
    Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.
    Xu Z; Xu P; Fan W; Yang G; Wang J; Cheng Q; Yu M
    Exp Ther Med; 2017 Oct; 14(4):3491-3500. PubMed ID: 29042938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Kay J; Fleischmann R; Keystone E; Hsia EC; Hsu B; Zhou Y; Goldstein N; Braun J
    J Rheumatol; 2016 Dec; 43(12):2120-2130. PubMed ID: 27803138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.